Procept biorobotics stock.
5 พ.ย. 2563 ... At PROCEPT BioRobotics, we are developing game changing surgical options for men in the treatment of BPH. Interested in being a part of the ...
PROCEPT BioRobotics has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500. Comparatively, Alphatec has a beta of 1.35, indicating that its stock price is 35% more volatile than the S&P 500.BofA Securities. Buy. $48. Show Previous Ratings. Nov-15-23 01:03AM. Insider Sell Alert: Director Morgan Wood Sells 25,000 Shares of PROCEPT BioRobotics Corp (PRCT) (GuruFocus.com) Nov-13-23 04:03PM. PROCEPT BioRobotics to Present at the 35 Annual Piper Sandler Healthcare Conference in New York City.Real time Procept BioRobotics (PRCT) stock price quote, stock graph, news & analysis. ... PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the ... 10 stocks we like better than PROCEPT BioRobotics Corporation When o ur award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade ...Currently, the analyst consensus on PROCEPT BioRobotics is a Strong Buy with an average price target of $47.80. See today’s best-performing stocks on TipRanks >> PRCT market cap is currently $1 ...
REDWOOD CITY, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by ...
Aug 4, 2022 · REDWOOD CITY, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended
Thursday, April 27, 2023 - Procept Biorobotics Corp ( PRCT) reported downside earnings and upside revenues. Procept Biorobotics Corp's earnings came in at an EPS loss of $0.63 per share, 9% lower than estimates for an EPS loss of $0.58 per share. The firm's loss per share expanded by 62% since reporting a loss of $0.39 per share a year ago.The PROCEPT BioRobotics 52-week low stock price is $24.83. What is the market capitalisation of PROCEPT BioRobotics PRCT? As of 01/12/2023 PROCEPT BioRobotics has a market cap of $1.9B.Nov 29, 2023 · 6 brokers have issued 12 month price objectives for PROCEPT BioRobotics' stock. Their PRCT share price targets range from $37.00 to $49.00. On average, they predict the company's share price to reach $43.00 in the next twelve months. This suggests a possible upside of 23.9% from the stock's current price. REDWOOD CITY, Calif., Sept. 21, 2021 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (“PROCEPT”), a commercial-stage surgical robotics company focused on advancing patient ...
PROCEPT BioRobotics Price Performance. Shares of PRCT opened at $37.00 on Thursday. The company has a market cap of $1.87 billion, a P/E ratio of -15.88 and a beta of 0.63. PROCEPT BioRobotics Co ...
On a more positive note, William Blair initiated coverage on PROCEPT BioRobotics with an “outperform” rating on the stock back in May. Based on data compiled by Bloomberg, PROCEPT BioRobotics currently holds a consensus rating of “Moderate Buy” among equity research analysts, with a consensus target price of $45.60 indicating optimism ...
SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing ...The stock of Procept BioRobotics Corp (PRCT) has gone up by 9.73% for the week, with a 48.65% rise in the past month and a 9.92% rise in the past quarter. The volatility ratio for the week is 4.42%, and the volatility levels for the past 30 days are 5.89% for PRCT. The simple moving […]PROCEPT BioRobotics is a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology. We develop, …Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t...PROCEPT BioRobotics Corp PRCT Morningstar Rating Stock XNAS Rating as of Nov 24, 2023 Summary Chart News Price vs Fair Value Sustainability …
PROCEPT BioRobotics’ stock opened at a price of $33.27 on Friday. The company boasts a current ratio of 6.40 and a quick ratio of 5.21 while maintaining a debt-to-equity ratio of 0.34. Notably, the company’s fifty-day simple moving average stands at $33.35 with a 200-day simple moving average at $33.23.Apr 19, 2023 · Procept Biorobotics Corp Stock Price History. Procept Biorobotics Corp’s price is currently up 20.7% so far this month. During the month of April, Procept Biorobotics Corp’s stock price has reached a high of $37.29 and a low of $28.80. Over the last year, Procept Biorobotics Corp has hit prices as high as $52.40 and as low as $25.90. Year ... REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a global leader... Menu icon A vertical stack of three evenly ...Procept Biorobotics Corp stock performance at a glance. Check Procept Biorobotics Corp’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. Main Lobby Procept BioRobotics Main Lobby Main Entrance Procept BioRobotics Main Entrance SAN JOSE, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT ...
REDWOOD CITY, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a surgical robotics company focused on advancing patient care ...PROCEPT BioRobotics Corporation is a surgical robotics company, which is focused on advancing patient care by developing transformative solutions in urology. The Company develops, manufactures and sells the AquaBeam Robotic System, which is an image-guided surgical robotic system for use in minimally invasive urologic surgery, with …
Apr 19, 2023 · Procept Biorobotics Corp Stock Price History. Procept Biorobotics Corp’s price is currently up 20.7% so far this month. During the month of April, Procept Biorobotics Corp’s stock price has reached a high of $37.29 and a low of $28.80. Over the last year, Procept Biorobotics Corp has hit prices as high as $52.40 and as low as $25.90. Year ... REDWOOD CITY, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics …Aug 1, 2023 · REDWOOD CITY, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a surgical robotics company focused on advancing patient care ... Procept Biorobotics Corp Stock Price History. Procept Biorobotics Corp’s price is currently up 17.51% so far this month. During the month of November, Procept Biorobotics Corp’s stock price has reached a high of $35.00 and a low of $26.44. Over the last year, Procept Biorobotics Corp has hit prices as high as $47.75 and as low as $24.83 ...REDWOOD CITY, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported financial results for the year ended December 31, 2022.. Recent Highlights . …32.82 -1.09 (-3.21%) Nov 6, 2023, 4:00 PM EST - Market closed Overview Financials Statistics Forecast Dividends Profile Chart Company Description PROCEPT …Shares of Procept Biorobotics (PRCT 0.19%) ... The stock is now down more than 31% so far this year. So what. Procept makes the AquaBeam Robotic System, which is designed to be used in performing ...Analysis of Insider Buy/Sell and Relationship with Stock Price. On November 13, 2023, Morgan Wood sold 25,000 shares of PROCEPT BioRobotics Corp at a price of $32.19 per share. This transaction ...AtriCure (NASDAQ:ATRC) and PROCEPT BioRobotics (NASDAQ:PRCT) are both small-cap medical companies, but which is the superior stock?We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, community ranking, earnings, …
About PROCEPT BioRobotics Stock. PROCEPT BioRobotics is a clinical-stage medical device company based in Silicon Valley. The Company has developed a disruptive surgical product for transurethral resection of prostate tissue – The AquaBeam® – and other treatment and diagnostic applications. The AquaBeam is a personalized image-guided tissue ...
PROCEPT BioRobotics is reporting earnings from Q3 on November 1. Wall Street analysts expect PROCEPT BioRobotics will release losses per share of $0.529. Track PROCEPT BioRobotics stock price in ...
Aug 4, 2022 · REDWOOD CITY, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.PROCEPT BioRobotics will host a conference call to discuss the second quarter 2022 financial results after the market close on Thursday, August 4th, 2022, at 1:30 p.m. Pacific Time / 4:30 p.m ...Nov 1, 2023 · PROCEPT BioRobotics Corporation RECONCILIATION OF GAAP NET LOSS TO ADJUSTED EBITDA (Unaudited, in thousands) Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022: Net loss $ (24,622) $ (22,613) $ (78,393) $ (58,982) Depreciation and amortization expense 1,054 703 2,489 2,178 Stock-based compensation expense 5,326 ... Nov 3, 2022 · PROCEPT BioRobotics Corporation is a surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial ... Nov 6, 2023 · PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). SAN JOSE, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the third... 12 Oct '23. Nov 1, 2023 · Disclaimer. Procept Biorobotics Corporation published this content on 01 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 November 2023 22:40:05 UTC. PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH).Aug 23, 2021 · Procept BioRobotics Corporation ( NASDAQ: PRCT) has filed to raise $100 million in an IPO of its common stock, according to an S-1 registration statement. The firm develops and commercializes ...
Nov 1, 2023 · PROCEPT BioRobotics also completed an equity follow-on offering, raising $162 million in net proceeds, and received FDA IDE approval for Aquablation Therapy for Prostate Cancer. PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance | PRCT Stock News 14 พ.ค. 2566 ... Silicon Motion (SIMO): Silicon Motion enjoys a zero-debt balance sheet. Procept BioRobotics (PRCT): Procept benefits from high fiscal stability.Procept Biorobotics Corp stock performance at a glance. Check Procept Biorobotics Corp’s past financial performance, like revenue or net income, plus the top level …PROCEPT BioRobotics also expects to grant the underwriters a 30- day option to purchase up to an additional $18,750,000 of shares of its common stock. All of the shares in the proposed offering ...Instagram:https://instagram. high monthly dividend etfwealth managment firmssntasurvey of consumer finances NVIDIA Corporation Common Stock. $416.10 +5.93 +1.45%. O. Realty Income Corporation Common Stock. $51.56 -0.50 -0.96%. PROCEPT BioRobotics Corporation Common Stock (PRCT) Pre-Market Stock Quotes ...The most recent slide in PROCEPT BioRobotics stock may reflect the dawning recognition from other investors that perhaps the share price is a bit too rich. After all, the company’s immediate market is less than $1 billion, according to our math. retail reitsbarton and gray mariners club In addition, PROCEPT BioRobotics has granted the underwriters a 30-day option to purchase up to an additional 663,325 shares of its common stock at the public offering price, less underwriting discounts and commissions. All of the shares in the offering are to be sold by PROCEPT BioRobotics. nasdaq xwel PROCEPT BioRobotics Corporation: RECONCILIATION OF GAAP NET LOSS TO ADJUSTED EBITDA (Unaudited, in thousands) Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Net loss $ (25,285) $ (19,184) $ (53,771) $ (36,369) Depreciation and amortization expense 642 717 1,435 1,475 Stock-based …PROCEPT BioRobotics Corporation (PRCT) Stock Historical Prices & Data - Yahoo Finance S&P 500 (+0.10%) Dow 30 -40.33(-0.12%) Nasdaq +10.56(+0.08%) Russell …31 พ.ค. 2566 ... Stock ratings and valuation methodologies: William Blair & Company, L.L.C. uses a three-point system to rate stocks. Individual ratings reflect ...